Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -18.292% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
(a) CCOc1cc(/C=C2/SC(=Nc3ccccc3)N(Cc3cccnc3)C2=O)ccc1OCC#N
(b) O=C(O)CSCC(=O)N1CCCN(c2nc3ccc(Cl)cc3s2)CC1
(c) Cn1ncc2c(N3CCN(c4ccc(Cl)c(Cl)c4)CC3)ncnc21
Answer: c. Cn1ncc2c(N3CCN(c4ccc(Cl)c(Cl)c4)CC3)ncnc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1ncc2c(N3CCN(c4ccc(Cl)c(Cl)c4)CC3)ncnc21
Cn1ncc2c(N3CCN(c4ccc(Cl)c(Cl)c4)CC3)ncnc21
4-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1-methylpyrazolo[3,4-d]pyrimidine